Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

2 Profitable Stocks with Solid Fundamentals and 1 We Turn Down

By: StockStory

August 25, 2026 at 00:35 AM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

CAH Cover Image

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my opportunity”.

A business making money today isn’t necessarily a winner, which is why we analyze companies across multiple dimensions at StockStory. That said, here are two profitable companies that generate reliable profits without sacrificing growth and one that may face some trouble.

One Stock to Sell:

Elanco (ELAN)

Trailing 12-Month GAAP Operating Margin: 1.6%

Originally established as a division of pharmaceutical giant Eli Lilly before becoming independent in 2018, Elanco Animal Health (NYSE: ELAN) develops and sells medications, vaccines, and other health products for pets and farm animals across more than 90 countries.

Why Does ELAN Fall Short?

Sales trends were unexciting over the last five years as its 2% annual growth was below the typical healthcare company
Efficiency has decreased over the last five years as its adjusted operating margin fell by 3.5 percentage points
Push for growth has led to negative returns on capital, signaling value destruction

Elanco is trading at $24.39 per share, or 20x forward P/E. Check out our free in-depth research report to learn more about why ELAN doesn’t pass our bar.

Two Stocks to Watch:

Cardinal Health (CAH)

Trailing 12-Month GAAP Operating Margin: 1%

Operating as a critical link in the healthcare supply chain since 1979, Cardinal Health (NYSE: CAH) distributes pharmaceuticals and manufactures medical products for hospitals, pharmacies, and healthcare providers across the global healthcare supply chain.

Why Does CAH Stand Out?

Massive revenue base of $254.2 billion in a highly regulated sector makes the company difficult to replace, giving it meaningful negotiating power
Share repurchases have amplified shareholder returns as its annual earnings per share growth of 14.6% exceeded its revenue gains over the last five years

At $235.23 per share, Cardinal Health trades at 18.3x forward P/E. Is now the right time to buy? Find out in our full research report, it’s free.

Kinder Morgan (KMI)

Trailing 12-Month GAAP Operating Margin: 29%

Operating what amounts to the toll roads of the energy industry, Kinder Morgan (NYSE: KMI) transports natural gas, refined petroleum products, and crude oil through its pipeline network across North America.

Why Are We Fans of KMI?

Enormous revenue base of $17.96 billion provides significant leverage in supplier negotiations
EBITDA margin improvement of 9.1 percentage points over the last five years demonstrates its ability to scale efficiently
Impressive free cash flow profitability enables the company to fund new investments or reward investors with share buybacks/dividends

Kinder Morgan’s stock price of $31.00 implies a valuation ratio of 21.1x forward P/E. Is now a good time to buy? See for yourself in our in-depth research report, it’s free.

High-Quality Stocks for All Market Conditions

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol	Price	Change (%)
AMZN	262.07	+0.00 (0.00%)
AAPL	310.34	+0.00 (0.00%)
AMD	456.75	+0.00 (0.00%)
BAC	62.33	+0.00 (0.00%)
GOOG	344.59	+0.00 (0.00%)
META	559.02	+0.00 (0.00%)
MSFT	487.31	+0.00 (0.00%)
NVDA	208.48	+0.00 (0.00%)
ORCL	142.45	+0.00 (0.00%)
TSLA	348.95	+0.00 (0.00%)